HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cyclin-Dependent Kinase Inhibitor p19

An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.
Also Known As:
CDKN2D Protein; Cyclin-Dependent Kinase Inhibitor 2D; INK4D Protein; p19INK4D Protein; Cyclin Dependent Kinase Inhibitor 2D; Cyclin Dependent Kinase Inhibitor p19
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Jiang, Xiuli: 1 article (07/2015)
2. Wang, Weiqing: 1 article (07/2015)
3. Gu, Weiqiong: 1 article (07/2015)
4. Cao, Yanan: 1 article (07/2015)
5. Ning, Guang: 1 article (07/2015)
6. Cheng, Yulong: 1 article (07/2015)
7. Su, Yutong: 1 article (07/2015)
8. Shan, Aijing: 1 article (07/2015)
9. Bartek, J: 1 article (08/2000)
10. Bartkova, J: 1 article (08/2000)

Related Diseases

1. Hematologic Neoplasms (Hematological Malignancy)
2. Thymoma (Thymic Carcinoma)
3. Testicular Neoplasms (Testicular Cancer)
4. Carcinoma in Situ

Related Drugs and Biologics

1. tensins (tensin)